Table: OncoTherapy Science - 9-MTH group results

OncoTherapy Science

07/02/2025 08:00

Feb 7 (Reuters)- 
             OncoTherapy Science Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2024        Dec 31, 2023     Mar 31, 2025 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            563 mln             466 mln                    
                 (+20.9 pct)         (-33.4 pct)                  
  Operating     loss 698 mln        loss 972 mln                  
  Recurring     loss 716 mln        loss 986 mln                  
  Net           loss 717 mln        loss 987 mln                  
  EPS           loss 2.78 yen       loss 4.68 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div
  -Q4 div                                NIL              NIL     
  
  NOTE - OncoTherapy Science Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4564.T